Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin (drospirenone/ethinylestradiol) post-marketing study in Chinese women
CTR20160203Phase 4Completed
- Sponsor
- Bayer
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of drospirenone in contraception, acne vulgaris, dysmenorrhea, sponsored by Bayer. Started Apr 2016; status: completed.
02
Drugs
drospirenone
03
Conditions
contraceptionacne vulgarisdysmenorrhea
Beyond the preview
Go deeper on CTR20160203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160203.